Comparing Retinal Structure in Patients with Achromatopsia and Blue Cone Monochromacy Using OCT.


Journal

Ophthalmology science
ISSN: 2666-9145
Titre abrégé: Ophthalmol Sci
Pays: Netherlands
ID NLM: 9918230896206676

Informations de publication

Date de publication:
Sep 2021
Historique:
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: ppublish

Résumé

To compare foveal hypoplasia and the appearance of the ellipsoid zone (EZ) at the fovea in patients with genetically confirmed achromatopsia (ACHM) and blue cone monochromacy (BCM). Retrospective, multi-center observational study. Molecularly confirmed patients with ACHM (n = 89) and BCM (n = 33). We analyzed high-resolution spectral domain optical coherence tomography (SD-OCT) images of the macula from aforementioned patients with BCM. Three observers independently graded SD-OCT images for foveal hypoplasia (i.e. retention of one or more inner retinal layers at the fovea) and four observers judged the integrity of the EZ at the fovea, based on an established grading scheme. These measures were compared with previously published data from the ACHM patients. Presence of foveal hypoplasia and EZ grade. Foveal hypoplasia was significantly more prevalent in ACHM than in BCM (p<0.001). In addition, we observed a significant difference in the distribution of EZ grades between ACHM and BCM, with grade II EZ being by far the most common phenotype in BCM (61% of patients). In contrast, ACHM patients had a relatively equal prevalence of EZ grades I, II, and IV. Interestingly, grade IV EZ was 2.6 times more prevalent in ACHM compared to BCM, while grade V EZ (macular atrophy) was present in 3% of both the ACHM and BCM cohorts. The higher incidence of foveal hypoplasia in ACHM than BCM supports a role for cone activity in foveal development. Although there are differences in EZ grades between these conditions, the degree of overlap suggests EZ grade is not sufficient for definitive diagnosis, in contrast to previous reports. Analysis of additional OCT features in similar cohorts may reveal differences with greater diagnostic value. Finally, the extent to which foveal hypoplasia or EZ grade is prognostic for therapeutic potential in either group remains to be seen, but motivates further study.

Identifiants

pubmed: 36186895
doi: 10.1016/j.xops.2021.100047
pmc: PMC9521040
mid: NIHMS1813866
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Medical Research Council
ID : MR/R012121/1
Pays : United Kingdom
Organisme : NEI NIH HHS
ID : R01 EY017607
Pays : United States

Références

Invest Ophthalmol Vis Sci. 2018 Dec 3;59(15):5762-5772
pubmed: 30516820
Am J Ophthalmol. 1983 Jun;95(6):741-7
pubmed: 6602551
Science. 1989 Aug 25;245(4920):831-8
pubmed: 2788922
Int Ophthalmol. 1992 May;16(3):185-6
pubmed: 1452423
Br J Ophthalmol. 2003 Nov;87(11):1317-20
pubmed: 14609822
Biomed Res Int. 2015;2015:782420
pubmed: 26221606
Am J Hum Genet. 2012 Sep 7;91(3):527-32
pubmed: 22901948
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1161-6
pubmed: 16505054
Hum Mutat. 2020 Jan;41(1):255-264
pubmed: 31544997
Ophthalmology. 2014 Jan;121(1):234-245
pubmed: 24148654
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):383-396
pubmed: 30682209
Graefes Arch Clin Exp Ophthalmol. 1985;223(2):55-9
pubmed: 3874117
Acta Ophthalmol (Copenh). 1991 Dec;69(6):711-6
pubmed: 1789084
Hum Gene Ther. 2013 Dec;24(12):993-1006
pubmed: 24067079
Am J Hum Genet. 2009 Aug;85(2):240-7
pubmed: 19615668
Mol Vis. 2009;15:876-84
pubmed: 19421413
Am J Hum Genet. 2002 Aug;71(2):422-5
pubmed: 12077706
Br J Ophthalmol. 2010 Mar;94(3):372-6
pubmed: 19770161
Retina. 2012 Jul;32(7):1411-9
pubmed: 22466470
Optom Vis Sci. 1996 Jul;73(7):446-56
pubmed: 8843124
Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):3984-95
pubmed: 27479814
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Invest Ophthalmol Vis Sci. 2012 Dec 05;53(13):8006-15
pubmed: 23139274
Exp Eye Res. 2004 Jun;78(6):1143-54
pubmed: 15109921
J Opt Soc Am. 1954 Feb;44(2):117-28
pubmed: 13131176
Ophthalmology. 2011 Dec;118(12):2315-25
pubmed: 21940051
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5952-7
pubmed: 20574029
Invest Ophthalmol Vis Sci. 2019 Dec 2;60(15):5112-5123
pubmed: 31826238
J Comp Neurol. 2019 Jan 1;527(1):38-51
pubmed: 28074469
Graefes Arch Clin Exp Ophthalmol. 2017 Feb;255(2):271-279
pubmed: 27491512
Optom Vis Sci. 1996 Jul;73(7):457-65
pubmed: 8843125

Auteurs

Emily J Patterson (EJ)

UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital, London, UK.

Christopher S Langlo (CS)

Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY, USA.

Michalis Georgiou (M)

UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital, London, UK.

Angelos Kalitzeos (A)

UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital, London, UK.

Mark E Pennesi (ME)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Jay Neitz (J)

Ophthalmology, University of Washington, Seattle, WA, USA.

Alison J Hardcastle (AJ)

UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital, London, UK.

Maureen Neitz (M)

Ophthalmology, University of Washington, Seattle, WA, USA.

Michel Michaelides (M)

UCL Institute of Ophthalmology, University College London, London, UK.
Moorfields Eye Hospital, London, UK.

Joseph Carroll (J)

Ophthalmology & Visual Sciences, Medical College of Wisconsin, Milwaukee, WI, USA.
Cell Biology, Neurobiology & Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.

Classifications MeSH